Clinical Trial Update: Immunogenicity of the Booster Dose of Two MenC Vaccines [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the immunogenicity of booster doses for two Meningococcal C vaccines; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infection

Drugs mentioned

• Meningococcal C conjugate vaccine (unspecified) – Vaccine 1 (Neisseria meningitidis serogroup C conjugate vaccine)
• Meningococcal C conjugate vaccine (unspecified) – Vaccine 2 (Neisseria meningitidis serogroup C conjugate vaccine)

Snippet

Sponsor: Centro Superior de Investigación en Salud Publica | Conditions: Meningococcal Infection | Phase 4 | Status: COMPLETED | Results posted: 2013-10-11